参考文献/References:
[1] Taqueti VR,di Carli MF. Coronary microvascular disease pathogenic mechanisms and therapeutic options:JACC state-of-the-art review[J]. J Am Coll Cardiol,2018,72(21):2625-2641.
[2] Kunadian V,Chieffo A,Camici PG,et al. An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group[J]. Eur Heart J,2020,41(37):3504-3520.
[3] Ong P,Safdar B,Seitz A,et al. Diagnosis of coronary microvascular dysfunction in the clinic[J]. Cardiovasc Res,2020,116(4):841-855.
[4] Bucciarelli-Ducci C,Pennell DJ. Low diagnostic yield of elective coronary angiography[J]. N Engl J Med,2010,363(1):94-95.
[5] Radico F,Cicchitti V,Zimarino M,et al. Angina pectoris and myocardial ischemia in the absence of obstructive coronary artery disease :practical considerations for diagnostic tests[J]. JACC Cardiovasc Interv,2014,7(5):453-463.
[6] Jespersen L,Hvelplund A,Abildstr?m SZ,et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events[J]. Eur Heart J,2012,33(6):734-744.
[7] Pepine CJ,Anderson RD,Sharaf BL,et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart,Lung and Blood Institute WISE (Women’s Ischemia Syndrome Evaluation) study[J]. J Am Coll Cardiol,2010,55(25):2825-2832.
[8] Vancheri F,Longo G,Vancheri S,et al. Coronary microvascular dysfunction[J]. J Clin Med,2020,9(9):2880.
[9] Valgimigli M,Campo G,Malagutti P,et al. Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction:a pooled analysis from the STRATEGY(Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY(Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials[J]. JACC Cardiovasc Interv,2011,4(1):51-62.
[10] Del Buono MG,Montone RA,Camilli M,et al. Coronary microvascular dysfunction across the spectrum of cardiovascular diseases:JACC state-of-the-art review[J]. J Am Coll Cardiol,2021,78(13):1352-1371.
[11] Mangiacapra F,Viscusi MM,Verolino G,et al. Invasive assessment of coronary microvascular function[J]. J Clin Med,2021,11(1):228.
[12] Gould KL,Kirkeeide RL,Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity[J]. J Am Coll Cardiol,1990,15(2):459-474.
[13] Layland J,Carrick D,Lee M,et al. Adenosine:physiology,pharmacology,and clinical applications[J]. JACC Cardiovasc Interv,2014,7(6):581-591.
[14] Gould KL,Lipscomb K,Hamilton GW. Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve[J]. Am J Cardiol,1974,33(1):87-94.
[15] Fearon WF,Farouque HM,Balsam LB,et al. Comparison of coronary thermodilution and Doppler velocity for assessing coronary flow reserve[J]. Circulation,2003,108(18):2198-2200.
[16] Pijls NH,de Bruyne B,Smith L,et al. Coronary thermodilution to assess flow reserve:validation in humans[J]. Circulation,2002,105(21):2482-2486.
[17] Everaars H,de Waard GA,Driessen RS,et al. Doppler flow velocity and thermodilution to assess coronary flow reserve:a head-to-head comparison with [15O]H2O PET[J]. JACC Cardiovasc Interv,2018,11(20):2044-2054.
[18] Knuuti J,Wijns W,Saraste A,et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes[J]. Eur Heart J,2020,41(3):407-477.
[19] Kern MJ. Coronary physiology revisited:practical insights from the cardiac catheterization laboratory[J]. Circulation,2000,101(11):1344-1351.
[20] de Bruyne B,Bartunek J,Sys SU,et al. Simultaneous coronary pressure and flow velocity measurements in humans. Feasibility,reproducibility,and hemodynamic dependence of coronary flow velocity reserve,hyperemic flow versus pressure slope index,and fractional flow reserve[J]. Circulation,1996,94(8):1842-1849.
[21] Camici PG,Crea F. Coronary microvascular dysfunction[J]. N Engl J Med,2007,356(8):830-840.
[22] Kelshiker MA,Seligman H,Howard JP,et al. Coronary flow reserve and cardiovascular outcomes:a systematic review and meta-analysis[J]. Eur Heart J,2022,43(16):1582-1593.
[23] Serruys PW,di Mario C,Piek J,et al. Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty:the DEBATE Study(Doppler Endpoints Balloon Angioplasty Trial Europe)[J]. Circulation,1997,96(10):3369-3377.
[24] Meimoun P,Malaquin D,Sayah S,et al. The coronary flow reserve is transiently impaired in tako-tsubo cardiomyopathy:a prospective study using serial Doppler transthoracic echocardiography[J]. J Am Soc Echocardiogr,2008,21(1):72-77.
[25] Al Suwaidi J,Velianou JL,Gertz MA,et al. Systemic amyloidosis presenting with angina pectoris[J]. Ann Intern Med,1999,131(11):838-841.
[26] Fearon WF,Balsam LB,Farouque HM,et al. Novel index for invasively assessing the coronary microcirculation[J]. Circulation,2003,107(25):3129-3132.
[27] Santos-Pardo I,Alstr?m P,Witt N. Index of microcirculatory resistance measured during intracoronary adenosine-induced hyperemia[J]. J Interv Cardiol,2020,2020:4829647.
[28] Ong P,Camici PG,Beltrame JF,et al. International standardization of diagnostic criteria for microvascular angina[J]. Int J Cardiol,2018,250:16-20.
[29] Kobayashi Y,Fearon WF. Invasive coronary microcirculation assessment—Current status of index of microcirculatory resistance[J]. Circ J,2014,78(5):1021-1028.
[30] Ng MK,Yeung AC,Fearon WF. Invasive assessment of the coronary microcirculation:superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve[J]. Circulation,2006,113(17):2054-2061.
[31] Kodeboina M,Nagumo S,Munhoz D,et al. Simplified assessment of the index of microvascular resistance[J]. J Interv Cardiol,2021,2021:9971874.
[32] Ahn JM,Zimmermann FM,Gullestad L,et al. Microcirculatory resistance predicts allograft rejection and cardiac events after heart transplantation[J]. J Am Coll Cardiol,2021,78(24):2425-2435.
[33] Allan T,Dryer K,Fearon WF,et al. Coronary microvascular dysfunction and clinical outcomes in patients with heart failure with preserved ejection fraction[J]. J Card Fail,2019,25(10):843-845.
[34] de Maria GL,Scarsini R,Shanmuganathan M,et al. Angiography-derived index of microcirculatory resistance as a novel,pressure-wire-free tool to assess coronary microcirculation in ST elevation myocardial infarction[J]. Int J Cardiovasc Imaging,2020,36(8):1395-1406.
[35] Choi KH,Dai N,Li Y,et al. Functional coronary angiography-derived index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction[J]. JACC Cardiovasc Interv,2021,14(15):1670-1684.
[36] de Waard GA,Fahrni G,de Wit D,et al. Hyperaemic microvascular resistance predicts clinical outcome and microvascular injury after myocardial infarction[J]. Heart,2018,104(2):127-134.
[37] Sheikh AR,Zeitz CJ,Rajendran S,et al. Clinical and coronary haemodynamic determinants of recurrent chest pain in patients without obstructive coronary artery disease—A pilot study [J]. Int J Cardiol,2018,267:16-21.
[38] Williams RP,de Waard GA,de Silva K,et al. Doppler versus thermodilution-derived coronary microvascular resistance to predict coronary microvascular dysfunction in patients with acute myocardial infarction or stable angina pectoris[J]. Am J Cardiol,2018,121(1):1-8.
[39] Canu M,Khouri C,Marliere S,et al. Prognostic significance of severe coronary microvascular dysfunction post-PCI in patients with STEMI:a systematic review and meta-analysis[J]. PLoS One,2022,17(5):e0268330.
[40] Toya T,Ahmad A,Corban MT,et al. Risk stratification of patients with nonobstructive coronary artery disease using resistive reserve ratio[J]. J Am Heart Assoc,2021,10(11):e020464.
[41] Gibson CM,Cannon CP,Daley WL,et al. TIMI frame count:a quantitative method of assessing coronary artery flow[J]. Circulation,1996,93(5):879-888.
[42] Ford TJ,Ong P,Sechtem U,et al. Assessment of vascular dysfunction in patients without obstructive coronary artery disease:why,how,and when[J]. JACC Cardiovasc Interv,2020,13(16):1847-1864.
[43] Kunadian V,Harrigan C,Zorkun C,et al. Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years[J]. J Thromb Thrombolysis,2009,27(3):316-328.
[44] Poyraz E,Sava? G,Erdem A,et al. The mean corrected TIMI frame count could predict major adverse cardiovascular events in patients with coronary slow-flow phenomenon[J]. Turk Kardiyol Dern Ars,2022,50(4):250-255.
[45] Konijnenberg LSF,Damman P,Duncker DJ,et al. Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction[J]. Cardiovasc Res,2020,116(4):787-805.
[46] Bethke A,Halvorsen S,B?hmer E,et al. Myocardial perfusion grade predicts final infarct size and left ventricular function in patients with ST-elevation myocardial infarction treated with a pharmaco-invasive strategy(thrombolysis and early angioplasty)[J]. EuroIntervention,2015,11(5):518-524.
[47] Gibson CM,Cannon CP,Murphy SA,et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs[J]. Circulation,2000,101(2):125-130.
[48] Ge H,Ding S,An D,et al. Frame counting improves the assessment of post-reperfusion microvascular patency by TIMI myocardial perfusion grade:evidence from cardiac magnetic resonance imaging[J]. Int J Cardiol,2016,203:360-366.
相似文献/References:
[1]鲁鹏,综述,蔡琳,等.冠状动脉钙化的研究新进展[J].心血管病学进展,2016,(2):176.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.021]
LU Peng,CAI Lin,HUANG Wei.New Progress of Coronary Artery Calcification[J].Advances in Cardiovascular Diseases,2016,(1):176.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.021]
[2]郑剑峰 邱洪.冠状动脉钙化研究进展[J].心血管病学进展,2020,(4):338.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.002]
ZHENG JianFengQIU Hong.Coronary Artery Calcification[J].Advances in Cardiovascular Diseases,2020,(1):338.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.002]
[3]孙一博 孙莉萍 董建增.血管炎的冠状动脉风险及手术治疗进展[J].心血管病学进展,2020,(8):821.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.010]
SUN YiboSUN LipingDONG Jianzeng.Coronary Risk and Progress in Surgical Therapy of Vasculitis[J].Advances in Cardiovascular Diseases,2020,(1):821.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.010]
[4]田婷 罗俊一 杨毅宁.一种罕见的冠状动脉异常——编织样冠状动脉[J].心血管病学进展,2020,(9):943.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.014]
TIAN Ting,LUO Junyi,YANG Yining.An Extremely Rare Anomaly of Coronary Artery[J].Advances in Cardiovascular Diseases,2020,(1):943.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.014]
[5]杨嘉馨 丁耀东 葛海龙.冠状动脉微循环功能的检测与评估[J].心血管病学进展,2021,(3):207.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.004]
YANG Jiaxin,DING Yaodong,GE Hailong.Detection and Assessment of Coronary Microcirculation Function[J].Advances in Cardiovascular Diseases,2021,(1):207.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.004]
[6]白梦雪 赵慧强.低分子右旋糖酐光学相干断层成像技术在冠状动脉疾病中的应用进展[J].心血管病学进展,2022,(2):103.[doi:10.16806/j.cnki.issn.1004-3934.20.02.003]
BAI MengxueZHAO Huiqiang.Application of Low Molecular Dextran Optical Coherence Tomography?n Coronary Arteries Disease[J].Advances in Cardiovascular Diseases,2022,(1):103.[doi:10.16806/j.cnki.issn.1004-3934.20.02.003]
[7]陈璐 王国宏 郭彩霞.冠状动脉CT血管成像对冠心病预后预测价值及治疗策略指导意义[J].心血管病学进展,2022,(2):108.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.004]
CHEN Lu,WANG Guohong,GUO Caixia.The Value of Coronary CT Angiography In Predicting the Prognosis and Treatment Strategies of Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2022,(1):108.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.004]
[8]李俊鹏 刘建 刘娜 杨欣荣 高婷 赵正凯.“三低”技术在CT体部血管一站式成像的应用价值[J].心血管病学进展,2022,(7):662.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
LI Junpeng,LIU Jian,LIU Na,et al.Application of Three Lows Technology in One-Stop Imaging of CT Body Vessels[J].Advances in Cardiovascular Diseases,2022,(1):662.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
[9]李明 张慧平.急性ST段抬高心肌梗死患者直接经皮冠状动脉介入治疗后微血管功能障碍再认识[J].心血管病学进展,2023,(3):193.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.001]
LI Ming,ZHANG Huiping.Coronary Microvascular Dysfunction in Patients with Acute ST Segment?levation Myocardial Infarction After Primary Percutaneous Coronary Intervention[J].Advances in Cardiovascular Diseases,2023,(1):193.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.001]
[10]徐明成 赵玉娟.甘油三酯葡萄糖指数对动脉粥样硬化性心血管疾病的预测价值[J].心血管病学进展,2023,(9):810.[doi:10.16806/j.cnki.issn.1004-3934.202.09.010]
Xu Mingcheng,ZHAO Yujuan.Predictive Value of Triglyceride Glucose Index in Atherosclerotic Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2023,(1):810.[doi:10.16806/j.cnki.issn.1004-3934.202.09.010]